Zobrazeno 1 - 4
of 4
pro vyhledávání: '"D Errico, T."'
Autor:
Caporali, R., Idolazzi, L., Bombardieri, S., Ferraccioli, G., Gerli, R., Govoni, M., Matucci-Cerinic, M., Pomponio, G., Salaffi, F., Tirri, R., Benaglio, F., Bianchino, L., Sarzi-Puttini, P., Adami, S., Afeltra, A., Altomonte, L., Arrigoni, E., Bagnato, G., Bianchi, G., Bucci, R. N., Caminiti, M., Cantini, F., Caputo, D., Carlino, G., Clerico, P., Colombelli, P., Corsaro, S. M., D Alessandro, G., Riso, L., Silva, S., D Errico, T., Di Matteo, L., Ferri, C., Foti, R., Fusaro, E., Gabrielli, A., Giacomelli, R., Lunardi, C., Malavolta, N., Martin Martin, L. S., Massarotti, M. S., Mazzone, A., Meschini, C., Migliore, A., Minisola, G., Monti, G., Muratore, M., Paoletti, F., Pappone, N., Passiu, G., Mario Pirisi, Pistone, G., Pozzi, M. R., Prandini, P., Provenzano, G., Ricioppo, A., Romeo, N., Russo, R., Saviola, G., Semeraro, A., Tartarelli, G., Tomietto, P., Valentini, G., Zuccaro, C.
Publikováno v:
Scopus-Elsevier
Objective To describe the effectiveness and safety of tocilizumab (TCZ), an interleukin-6 receptor inhibitor, in a cohort of patients with rheumatoid arthritis (RA) recruited in clinical practice. Methods TRUST was an observational study in RA patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b45ac161fb8e96c4601b4e91e34f216c
http://hdl.handle.net/11591/393215
http://hdl.handle.net/11591/393215
Autor:
Caporali, R., Idolazzi, L., Bombardieri, S., Ferraccioli, G., Gerli, R., Govoni, M., Matucci-Cerinic, M., Pomponio, G., Fausto SALAFFI, Tirri, R., Benaglio, F., Bianchino, L., Sarzi-Puttini, P., Adami, S., Afeltra, A., Altomonte, L., Arrigoni, E., Bagnato, G., Bianchi, G., Bucci, R. N., Caminiti, M., Cantini, F., Caputo, D., Carlino, G., Clerico, P., Colombelli, P., Corsaro, S. M., D Alessandro, G., Riso, L., Silva, S., D Errico, T., Di Matteo, L., Ferri, C., Foti, R., Fusaro, E., Gabrielli, A., Giacomelli, R., Lunardi, C., Malavolta, N., Martin Martin, L. S., Massarotti, M. S., Mazzone, A., Meschini, C., Migliore, A., Minisola, G., Monti, G., Muratore, M., Paoletti, F., Pappone, N., Passiu, G., Pirisi, M., Pistone, G., Pozzi, M. R., Prandini, P., Provenzano, G., Ricioppo, A., Romeo, N., Russo, R., Saviola, G., Semeraro, A., Tartarelli, G., Tomietto, P., Valentini, G., Zuccaro, C.
Publikováno v:
Scopus-Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1ccdaa4362203b8ec3a96da077fef3ef
http://www.scopus.com/inward/record.url?eid=2-s2.0-85040549739&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-85040549739&partnerID=MN8TOARS
Autor:
Salvio, A., Mormile, M., Giannattasio, F., Varriale, M., D Errico, T., Balzano, B., Pierluigi Carratù, Tufano, G., Visconti, M.
Publikováno v:
Scopus-Elsevier
Interferon (IFN)-alpha with or without ribavirin is the treatment of choice for patients with chronic HCV-related hepatitis. Cough and dyspnea during IFN therapy are often regarded as a side effect and not as a possible sign of the onset of a pulmona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8257c05f655292a43ce4a4a3dbb2c340
http://www.scopus.com/inward/record.url?eid=2-s2.0-3042528743&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-3042528743&partnerID=MN8TOARS
Autor:
Varriale, M., Salvio, A., Giannattasio, F., D Errico, T., Montone, L., Borgia, F., Ivan Gentile, Reynaud, L., Borgia, G., Rossiello, R., Visconti, M.
Publikováno v:
Scopus-Elsevier
Ranitidine may cause liver injuries ranging from transient, subclinical serum transaminases increase every 100-1,000 treated patients to cholestatic hepatitis in less than 1/100,000. Other H2-receptor antagonists are more dangerous: 11 toxic hepatiti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::916d3a206c27bd3feb2b6fd8273e6af0
http://www.scopus.com/inward/record.url?eid=2-s2.0-20644434907&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-20644434907&partnerID=MN8TOARS